FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Hydrocortisone Acetate And Pramoxine Hydrochloride Kit Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
DESCRIPTION: Hydrocortisone Acetate 2.5%-Pramoxine HCI 1 % Cream is a topical preparation containing Hydrocortisone Acetate 2.5% w/w and Pramoxine HCI 1 % w/w in a hydrophilic base containing purified water, cetostearyl alcohol, mineral oil, white petrolatum, propylparaben, triethanolamine laurel sulfate, citric acid, sodium citrate, isopropyl palmitate, stearic acid, lanolin alcohol, methyl paraben, potassium sorbate, sorbic acid, PEG-40 stearate and ceresin wax. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below.
Sources
Hydrocortisone Acetate And Pramoxine Hydrochloride Kit Manufacturers
-
Acella Pharmaceuticals, Llc
Hydrocortisone Acetate And Pramoxine Hydrochloride Kit | Acella Pharmaceuticals, Llc
DOSAGE AND ADMINISTRATION: Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Login To Your Free Account